Vivaldi Capital Management LP Buys 45 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Vivaldi Capital Management LP raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the fourth quarter, Holdings Channel reports. The fund owned 2,483 shares of the healthcare conglomerate’s stock after purchasing an additional 45 shares during the quarter. Vivaldi Capital Management LP’s holdings in UnitedHealth Group were worth $1,350,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the 4th quarter worth approximately $30,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $291.24 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s fifty day simple moving average is $470.82 and its two-hundred day simple moving average is $513.25. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a market cap of $264.20 billion, a PE ratio of 18.79, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the business posted $6.91 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.88%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research report on Wednesday, May 14th. Finally, Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Six analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $486.00.

Insider Transactions at UnitedHealth Group

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 in the last ninety days. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.